Aptevo Therapeutics Inc. has announced a change in its independent registered public accounting firm following the merger of Moss Adams LLP with Baker Tilly US, LLP, effective June 3, 2025. As a result, Moss Adams has resigned, and Baker Tilly has been appointed as the company's new independent auditor for the year ending December 31, 2025, effective June 23, 2025. During the transition, there were no disagreements or reportable events between Aptevo and Moss Adams concerning accounting principles or financial statement disclosures. Moss Adams has confirmed agreement with these statements in a letter to the Securities and Exchange Commission.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.